Back

Comparison of QT interval readings between smartwatch ECG combined with artificial intelligence and 12-lead ECG in subjects hospitalized for antiarrhythmic drug initiation and follow-up

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: eCardiology 3 Artificial Intelligence EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Baptiste Lefebvre

Philips Cardiologs, Paris (France)

7 More presentations in this session

Presentation thumbnail
Genetic, sociodemographic, lifestyle, and clinical risk factors of heart failure aggravation events: data from the UK Biobank
Doctor T. Hwang (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Spatiotemporal stability of digital twin-guided atrial fibrillation dominant frequency sites and the clinical outcome of catheter ablation
Doctor T. Hwang (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Initial experience with a virtual atrial fibrillation clinic after pulmonary vein isolation
Doctor J. Balt (Nieuwegein, NL)
Abstract Slides Video
Presentation thumbnail
Artificial Intelligence-based Electrocardiogram prediction for duration of Atrial Fibrillation
Doctor Y. Park (Seoul, KR)
Abstract Slides Video
Presentation thumbnail
Predicting left atrial appendage thrombus in patients with persistent atrial fibrillation or flutter and no oral anticoagulation using machine-learning models.
Doctor B. Musielak (Nowa Sol, PL)
Abstract Slides Video

Access the full session

Session thumbnail
eCardiology 3

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
Clinical validation of an artificial intelligence algorithm offering automated corrected QT-interval measurements from a single lead electrocardiogram
thumbnail
Congress Presentation
Prediction of QT interval in ECGs through baseline wander removal and deep learning technique
thumbnail
Congress Presentation
Long-term QT interval analysis for real world patients with Insertable cardiac monitors taking antiarrhythmic drugs

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources